VIDAR-1 trial marks company’s clinical-stage debut
News
Careology and Entia join forces to transform cancer care
Collaboration brings remote care to cancer patients
Rxulti approved in the European Union for adolescent schizophrenia
EC extends brexpiprazole indication to include adolescents
Grifols clinical trial shows positive results for post-polio patients
Immunoglobulin therapy improves mobility in phase 2/3 study
Minoryx doses first patient with leriglitazone in Rett syndrome study
Phase 2a TREE study assesses safety and efficacy of leriglitazone
Orphelia Pharma explores other pathways for paediatric cancer treatment
Company seeks new direction after negative CHMP opinion on KIZFIZO
Dementia drug neflamapimod shows positive phase 2b trial results
CervoMed’s therapy demonstrates significant improvement in patients
New weight-loss pill shows promising results
Oxford Medical Products targets overweight individuals
Agomab announces positive phase 2a interim results for AGMB-129
FSCD therapy meets all endpoints in interim analysis
Pfizer’s Talzenna therapy accepted for use within NHS Scotland
Scottish Medicines Consortium approves new option for mCRPC patients
Leqembi enters second consultation period following NICE draft guidance update
NICE convenes third committee meeting for additional appraisal consideration
NHS patients receive UK-donated plasma medicines for first time in 30 years
Octapharma supports NHS in building resilient supply chain
SECuRE trial pre-chemo participants experience PSA level drops
Cohort expansion phase commences with promising results
Rotherham NHS Foundation Trust enhances patient engagement
Innovative digital transformation leads to significant improvements
Centauri therapeutics selects first ABX-01 clinical candidate
Lead candidate for lung infections moves to human trials
